Blog - Yseop 2024年11月27日
Yseop Joins Veeva’s AI Partner Program to Accelerate Regulatory Document Writing and AI-Driven Content Automation
index_new5.html
../../../zaker_core/zaker_tpl_static/wap/tpl_guoji1.html

 

Yseop宣布加入Veeva AI合作伙伴计划,旨在通过人工智能加速制药行业监管文档的编写流程。Yseop Copilot与Veeva Vault RIM的集成,将帮助生命科学领域的客户提高可见性、数据质量和敏捷性,加速医疗写作流程。该合作将利用生成式AI技术,实现一键式文档创建和管理,从而减少药物上市时间,提高医疗撰稿人的工作效率。Veeva AI战略的一部分是确保客户能够无缝使用AI应用程序,而Yseop Copilot正是其中之一,它可以简化监管文档流程,提高效率。

🤔Yseop加入Veeva AI合作伙伴计划,旨在通过人工智能技术加速制药行业监管文档的编写流程,包括数据采集、撰写、内容开发、验证和提交等环节,从而缩短药物上市时间。

🚀Yseop Copilot与Veeva Vault RIM的集成,将帮助生命科学领域的客户提高可见性、数据质量和敏捷性,加速医疗写作流程,例如报告和洞察力的生成。

💡Yseop Copilot的生成式AI功能,可以实现一键式文档创建和管理,提高医疗撰稿人的工作效率,例如报告、协议、摘要等文档。

🤝Veeva AI战略的一部分是确保客户能够无缝使用AI应用程序,而Yseop Copilot正是其中之一,它可以简化监管文档流程,提高效率,例如简化提交流程、减少错误等。

📅Yseop赞助Veeva研发与质量峰会,探讨如何提升临床运营、优化临床数据以及改进监管提交,以提高效率和生产力。

Yseop, a leader in artificial intelligence (AI) enterprise software, is excited to announce it has joined the Veeva AI Partner Program. As a Veeva AI partner, Yseop is helping to transform the regulatory document workflow process — from data ingestion, authoring, and content development to validation and submission —accelerating the time it takes to bring new drugs to market.

Yseop Copilot empowers regulatory teams and medical writers with AI-driven content workflow automation, boosting productivity and efficiency for regulatory documents. The integration between Yseop Copilot and Veeva Vault RIM will further enable mutual life sciences customers to improve visibility, data quality, and agility, and accelerate medical writing workflows. Biopharmas using Vault RIM for regulatory content management will be able to benefit from Yseop Copilot’s intelligent Generative AI capabilities, enabling single-click document creation and management.

“Veeva’s leadership in the Biopharma software space makes this integration a significant milestone, further extending Yseop Copilot’s reach across the life sciences sector,” said Emmanuel Walckenaer, CEO of Yseop. “We’re proud to contribute to Veeva’s AI Partner Program, enhancing their regulatory content management experience and helping the industry reduce time to market while allowing medical writers to operate more efficiently within familiar workflows.”

“A significant part of Veeva’s AI strategy is ensuring customers have access to AI applications that work seamlessly with the Veeva Vault platform, such as Yseop,” said Marc Gabriel, Vice President, Veeva Vault RIM. “By collaborating with Yseop, our complementary technologies can speed regulatory document writing and workflows so mutual customers can streamline the regulatory documentation process.”

Yseop is proud to sponsor Veeva R&D and Quality Summit in Boston, September 9-10. Key topics include enhancing clinical operations, optimizing clinical data, and improving regulatory submissions to boost efficiency and productivity. For more information about our integration with Veeva or to request a meeting at the Veeva R&D and Quality Summit, please contact us here.

About Yseop

Yseop is the leader in Generative AI for life science and pharmaceutical companies, changing the way content automation solutions are delivered with a human-centric, AI platform. Yseop is a pioneer in Natural Language Processing (NLP) technology and acts as a “Copilot” for medical writers, maximizing their efficiency and accuracy in generating reports and insights crucial to drug development and approval.

Media Contacts
FischTank PR
yseop@fischtankpr.com

 

Amicie OUREGA D.
Marketing Manager EMEA
aourega@yseop.com

 

The post Yseop Joins Veeva’s AI Partner Program to Accelerate Regulatory Document Writing and AI-Driven Content Automation appeared first on Yseop.

Fish AI Reader

Fish AI Reader

AI辅助创作,多种专业模板,深度分析,高质量内容生成。从观点提取到深度思考,FishAI为您提供全方位的创作支持。新版本引入自定义参数,让您的创作更加个性化和精准。

FishAI

FishAI

鱼阅,AI 时代的下一个智能信息助手,助你摆脱信息焦虑

联系邮箱 441953276@qq.com

相关标签

Yseop Veeva AI 监管文档 制药
相关文章